French company bets $350 million on success of New York-based Regeneron Pharmaceuticals By: Albany Business Review via Business Journals July 11, 2014 at 06:18 AM EDT Regeneron Pharmaceuticals Inc., a New York drug developer, is on the verge of making its next big money maker... Read More >> Related Stocks: Sanofi-Aventis S.A. ADR